Recurrence of Pyoderma Gangrenosum Potentially Triggered by COVID-19 Vaccination

  • Clark A
  • Williams B
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Pyoderma gangrenosum (PG) is a rare inflammatory skin disease of unknown origin. As with other vaccines, COVID-19 vaccines have been associated with many cutaneous reactions. Although COVID-19 vaccination is crucial, it is important for dermatologists and other physicians to be aware of the possible cutaneous reactions that can occur following COVID-19 vaccination. In this report, we describe a 73-year-old woman with a personal history of PG who experienced a recurrence after receiving her second dose of the tozinameran vaccine. Although extremely rare, flares of other inflammatory dermatoses, including lichen planus, have been reported following COVID-19 vaccination. Here we discuss the overlap in pathogenesis of PG and COVID-19, proposing possible mechanisms behind this rare phenomenon.

Cite

CITATION STYLE

APA

Clark, A. L., & Williams, B. (2022). Recurrence of Pyoderma Gangrenosum Potentially Triggered by COVID-19 Vaccination. Cureus. https://doi.org/10.7759/cureus.22625

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free